NJ man had a 5% of surviving esophageal cancer; 25 years later, he's still helping others
Bart Frazzitta was told he had a 5% chance of surviving esophageal cancer. Twenty-five years later, he's still here and ...
The New England Journal of Medicine24d
Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer
we assigned in a 1:1 ratio patients with resectable esophageal adenocarcinoma to receive perioperative chemotherapy with FLOT (fluorouracil, leucovorin, oxaliplatin, and docetaxel) plus surgery or ...
Healio11d
Travel to high-volume centers for esophageal cancer surgery linked to longer survival
Patients who traveled to high-volume centers for esophagectomy experienced better outcomes than those who sought treatment ...
HealthDay on MSN14d
Perioperative Chemo With FLOT Ups Survival in Resectable Esophageal Cancer
HealthDay News — For patients with resectable esophageal adenocarcinoma, perioperative chemotherapy with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) leads to improved survival compared ...
app.com11d
NJ man had 5% chance of surviving esophageal cancer; 25 years later, he's helping others
The good news was a treatment plan that consisted of six weeks of intensive chemotherapy and radiation, followed by surgery that takes out two-thirds of the esophagus and one-third of the stomach ...